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Combinatorial modiﬁcations of the core histones have the
potential to ﬁne-tune the epigenetic regulation of chroma-
tin states. The Aurora B kinase is responsible for generat-
ing the double histone H3 modiﬁcation tri-methylated K9/
phosphorylated S10 (H3K9me3/S10ph), which has been
implicated in chromosome condensation during mitosis.
In this study, we have identiﬁed a novel role for Aurora B
in epigenetic marking of silent chromatin during cell
differentiation. We ﬁnd that phosphorylation of H3 S10
by Aurora B generates high levels of the double H3K9me3/
S10ph modiﬁcation in differentiated postmitotic cells and
also results in delocalisation of HP1b away from hetero-
chromatin in terminally differentiated plasma cells.
Microarray analysis of the H3K9me3/S10ph modiﬁcation
shows a striking increase in the modiﬁcation across re-
pressed genes during differentiation of mesenchymal stem
cells. Our results provide evidence that the Aurora B
kinase has a role in marking silent chromatin inde-
pendently of the cell cycle and suggest that targeting of
Aurora B-mediated phosphorylation of H3 S10 to repressed
genes could be a mechanism for epigenetic silencing of
gene expression.
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Introduction
Establishing speciﬁc gene expression programmes during cell
differentiation requires controlled activation and silencing of
large numbers of genes. Once these patterns of expression or
repression have been set up, they must be kept in place to
maintain the identity of the differentiating cell. Chromatin is
known to play a key role in these processes. It can exert its
effects both at the local level, with single nucleosomes
modulating access of factors to promoters and enhancers,
and on a more global level through large-scale condensation
of megabase regions or even entire chromosomes (Heard,
2005; Dillon, 2006). Chromatin-mediated silencing of gene
expression is strongly inﬂuenced by epigenetic modiﬁcations
of the core histones, which include methylation and acetyla-
tion of lysine residues and phosphorylation of serine resi-
dues. These modiﬁcations can directly affect chromatin
packaging as well as inﬂuence the binding of chromatin
proteins and transcription factors (reviewed in Turner, 2007).
The presence of epigenetic modiﬁcations can alter the
structure of gene expression domains that include the gene
and surrounding sequences, and when these modiﬁcations
extend over larger regions, they facilitate packaging of the
DNA into visibly condensed heterochromatin. Constitutive
heterochromatin, which is present throughout the cell cycle,
is relatively gene poor and enriched for repetitive satellite
sequences. Facultative heterochromatin is quite different in
that it is the result of a developmentally regulated condensa-
tion of gene-rich euchromatic regions, which are decon-
densed and transcriptionally active in some cell types.
Some of the most dramatic examples of facultative hetero-
chromatin are observed during the ﬁnal stages of cell differ-
entiation. Terminally differentiated cells that exhibit this type
of widespread heterochromatinisation include rod photore-
ceptor cells (Araki et al, 1988), neutrophils (Olins and Olins,
2005), nucleated erythrocytes (Gilbert et al, 2003) and plasma
cells (Schulze et al, 1984). It seems likely that formation of
facultative heterochromatin during cell differentiation in-
volves at least some of the silencing mechanisms that affect
gene expression locally. This suggests that there may be a
point during cell differentiation when these local gene-silen-
cing events reach a critical mass that is sufﬁcient to give rise
to visibly condensed facultative heterochromatin.
Methylation of histone H3 lysine 9 (K9) has been shown to
be involved in epigenetic silencing of euchromatic genes and
also marks the constitutive heterochromatin that is found
close to centromeres (Bannister et al, 2001; Nielsen et al,
2001; Ayyanathan et al, 2003; Hediger and Gasser, 2006). An
important function of methylated H3K9 groups is to act as a
recognition site for heterochromatin protein 1 (HP1), which
binds to the methylated lysine via the chromodomain region
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4657(Lachner et al, 2001). HP1 was originally identiﬁed as a
modiﬁer of position effect variegation in Drosophila and has
been shown to associate strongly with constitutive hetero-
chromatin. There is also evidence that it is recruited directly
to some gene promoters where it participates in transcrip-
tional silencing (Nielsen et al, 2001; Ogawa et al, 2002;
Ayyanathan et al, 2003). Three HP1 proteins have been
identiﬁed in mammals (a, b and g). HP1a is mainly asso-
ciated with constitutive heterochromatin, HP1b is present
both on pericentric heterochromatin and euchromatin,
whereas HP1g is predominantly euchromatic (Minc et al,
1999).
Binding of HP1 to H3K9 has been shown to be affected by
the presence of a phosphate group at serine 10 (S10ph).
Phosphorylation of H3 S10 during G2/M has been found to
prevent HP1b from binding to the adjacent H3K9me residue.
As a result, HP1b is released from chromatin at the onset of
mitosis (Fischle et al, 2005; Hirota et al, 2005). The kinase
responsible for S10 phosphorylation is the Aurora B kinase, a
component of the chromosomal passenger complex, which
modulates chromosome structure and segregation at mitosis
by promoting HP1 displacement from the chromosomes, and
chromosome alignment and attachment to the microtubules
of the mitotic spindle (Vader et al, 2006). The other subunits
of the complex, INCENP, Survivin and Borealin, are non-
enzymatic and are involved in regulating and targeting
Aurora B to its substrates. In non-transformed cells, Aurora
B has, until now, been considered to be highly cell-cycle
regulated and to be involved primarily in protein phosphor-
ylation during mitosis. The double histone H3 tri-methylated
K9/phosphorylated S10 (H3K9me3/S10ph) modiﬁcation
generated by Aurora B is known to be widely distributed on
mitotic chromosomes, and inhibition of S10 phosphorylation
has been shown to interfere with chromosome condensation
during mitosis (Hendzel et al, 1997; Van Hooser et al, 1998;
Wei et al, 1998). The double modiﬁcation has been proposed
to be a marker of M phase (Fischle et al, 2005), but it has not
been shown previously to be involved in modulating chro-
matin structure outside mitosis.
Here we show that in addition to its functions during
mitosis, the Aurora B kinase mediates formation of the
double H3K9me3/S10ph modiﬁcation independently of the
cell cycle during cell differentiation. In terminally differen-
tiated postmitotic plasma cells, this results in displacement of
HP1b from facultative heterochromatin. We also use micro-
array analysis to demonstrate the presence of domains of
H3K9me3/S10ph at silent genes in differentiated cells. Our
results suggest that binary modiﬁcations can play an impor-
tant role in modulating the effects of speciﬁc histone modi-
ﬁcations at different stages of development.
Results
Experimental systems
To identify epigenetic markers that are involved in long-term
silencing of gene expression during cell differentiation, we
initially screened facultative heterochromatin in terminally
differentiated bone marrow plasma cells for the presence of
candidate marks that might play a role in silencing. The
results of this analysis revealed an unexpected correlation
between the presence of visible heterochromatin and the
binary K9me3/S10ph modiﬁcation on histone H3. The double
modiﬁcation was detected by immunoﬂuorescence (IF) using
an antibody that speciﬁcally recognises these modiﬁcations
when they are present in combination on the same histone
H3 molecule (Figure 1A). The speciﬁcity of the antibody was
conﬁrmed by western blotting (Supplementary Figure S2),
peptide ELISA and peptide competition, which showed that it
did not crossreact with tri-methyl K9 (K9me3) alone, phos-
pho-S10 (S10ph) alone, di-methyl K9/phospho-S10 (K9me2/
S10ph) or tri-methyl K27/phospho-S28 (K27me3/S28ph)
(Figure 1A). Analysis by IF using this antibody showed strong
staining of facultative heterochromatin in 100% of bone
marrow plasma cells. A particularly striking aspect of this
result is the fact that plasma cells are postmitotic, whereas
the double modiﬁcation had previously been thought to be
associated with the G2/M phase of the cell cycle and dis-
placement of HP1 from mitotic chromosomes. This ﬁnding
led us to perform a detailed analysis of the role of the double
H3K9me3/S10ph modiﬁcation in heterochromatin formation
and epigenetic marking of silent genes during cell commit-
ment and differentiation.
The model systems that were used for the analysis were
differentiation of mesenchymal stem cells and terminal dif-
ferentiation of B cells into plasma cells (Figure 1B and C). The
multipotent mesenchymal stem cell line C3H10T1/2 can be
induced to differentiate into osteocytes, chondrocytes and
adipocytes and has been used extensively as an in vitro model
for mesenchymal stem cell differentiation (Shea et al, 2003).
In this study, the cells were differentiated into osteocytes by
treatment with thyroxine and dexamethasone (Peister et al,
2004). Plasma cells were generated in vitro by differentiation
of primary splenic B cells (see Materials and methods and
Supplementary Figure S1). Terminal differentiation of B cells
into plasma cells is accompanied by widespread gene silen-
cing and formation of facultative heterochromatin as the cell
becomes specialised for the production and secretion of large
amounts of antibody (Underhill et al, 2003). The in vitro
differentiation system (Supplementary Figure S1) offered the
advantage of providing enough plasma cells for chromatin
analysis.
Because of the known link between the presence of the
double modiﬁcation and mitosis, the cell division status of
the cells was determined before and after differentiation by
measurement of bromodeoxyuridine (BrdU) incorporation
(Figure 1D). The activated B cells were clearly cycling (75%
BrdU
þ), whereas the plasma cells were almost entirely
postmitotic (3% BrdU
þ). The undifferentiated C3H10T1/2
mesenchymal stem cells were also actively cycling (89%
BrdU
þ) and became largely postmitotic after differentiation
(8% BrdU
þ).
The histone H3K9me3/S10ph double modiﬁcation
becomes enriched on chromatin of differentiated
postmitotic cells
The mesenchymal stem-cell and B-cell differentiation systems
were used to analyse the distribution of the double modiﬁca-
tion before and after cell differentiation and exit from the cell
cycle. Immunostaining was carried out using the anti-
H3K9me3/S10ph antibody. Staining of the undifferentiated
mesenchymal stem cells showed a strong punctate staining
for the double modiﬁcation in 23% of the cells. The punctu-
ate staining coincided with the DAPI-dense pericentromeric
heterochromatin (Figure 2A). The larger size of these cells
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FACS analysis of the level of the double modiﬁcation in cells
that were gated according to DNA content (Figure 2D). The
results of the immunostaining and FACS are in agreement
with the observation by Fischle et al (2005) of a global
increase in H3K9me3/S10ph that coincides with the onset
of G2/M. The staining was much lower in the remaining cells
and many of the cells showed little signal. The variation in
the signal that was observed in the dull cells is likely to reﬂect
progression through the different stages of the cell cycle. A
quite different result was obtained when the cells were
induced to differentiate along the osteogenic pathway. The
differentiated postmitotic cells showed staining in the nuclei
of all the cells analysed (Figure 2A). The staining in the
differentiated cells was found at the pericentromeric hetero-
chromatin and also as a more diffuse signal that appeared to
extend over much of the rest of the chromatin.
In the activated B-cell cultures, 27% of the cells showed a
strong punctate staining for the double modiﬁcation. Once
again, the larger size of the positive cells and the FACS
analysis identiﬁed them as being in G2 (Figure 2B and E).
A smaller proportion (16%) showed an intermediate staining
of the pericentromeric heterochromatin, but the majority of
the cells (56%) were negative for the double modiﬁcation.
The differentiated plasma cells showed a very strong nuclear
staining in approximately 60% of the cells, despite the fact
that these cells were clearly postmitotic. In the positively
staining cells, the signal for H3K9me3/S10ph was particularly
intense on the large masses of DAPI-dense facultative hetero-
chromatin, but was also present as a more diffuse staining on
the rest of the chromatin (Figure 2B). The observation that
around 40% of the cells were negative for the double
modiﬁcation could be related to the fact that these are
short-lived plasma cells in which a proportion of the cells
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Figure 1 Increased levels of H3K9me3/S10ph in plasma cell chromatin. (A) Immunoﬂuorescence (IF) analysis of the distribution of H3K9me3/
S10ph in bone marrow plasma cells (PC). Plasma cells (indicated by arrows) were identiﬁed by high levels of cytoplasmic immunoglobulins
(Igs). Scale bar¼10 mm. Histograms represent a peptide ELISA assay showing that the a-H3K9me3/S10ph antibody has high afﬁnity for a
peptide spanning aa 5–13 of histone H3 containing K9me3 and S10ph (1) and has negligible crossreactivity with peptides of the same region
with either K9me3 alone (2) or K9me2/S10ph (3) or a peptide corresponding to aa 24–33 of H3 containing K27me3/S28ph (4). Western blotting
with the a-H3K9me3/S10ph antibody shows that a peptide corresponding to aa 5–13 of histone H3 containing S10ph alone does not compete
for binding to the epitope in a peptide competition assay. (B) Scheme showing the stages of B-cell development. Rearrangement of heavy- and
light-chain Ig genes at the pro- and pre-B-cell stages gives rise to resting B cells, which are activated by encounter with antigen and differentiate
into postmitotic antibody-secreting plasma cells. ProB, preB¼progenitor and precursor B cells; rest B¼resting B cells; act B¼activated
B cells. (C) Cell lineages originating from differentiation of C3H10T1/2 mesenchymal stem cells. (D) Bromodeoxyuridine (BrdU) incorporation
in activated B cells, plasma cells and mesenchymal cells. The cells were incubated in medium with 10mM BrdU. Incorporation of BrdU was
measured by staining with FITC-conjugated a-BrdU antibody (Beckton and Dickinson) and FACS analysis. Staining for BrdU in the cell
populations (black) is compared to background levels of autoﬂuorescence in unstained cells (blue).
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apoptotic changes. It should be noted that bone marrow
plasma cells, which have been shown to be long-lived
(Calame, 2006), showed a strong staining for the double
modiﬁcation in all the cells analysed (Figure 1A).
The staining pattern for H3K9me3/S10ph was compared
with the pattern obtained using an antibody that was speciﬁc
for H3K9me3 alone (Figure 2C). There was no difference in
the level and distribution of the single modiﬁcation between
undifferentiated and differentiated mesenchymal stem cells.
Ig
DAPI
A
PC
PC
In vitro
PC
Undiff
C3H10
Diff
C3H10
DAPI
B
actB
C
DAPI
Undiff
C3H10
Diff
C3H10
H3K9me3
actB
In vitro
PC
DAPI
Ig
H3K9me3/S10ph
H3K9me3/S10ph
H3K9me3
DNA content (PI)
actB
Undiff C3H10
G1
G2/M
H3K9me3/S10ph
G1
G2/M
G1 G2/M
DNA content (PI)
H3K9me3/S10ph
G1
G2/M
D
E
Figure 2 Distribution of the histone H3K9me3/S10ph double modiﬁcation during cell differentiation. (A) H3K9me3/S10ph staining before and
after differentiation of C3H10T1/2 mesenchymal stem cells. (B) H3 me3K9/pS10 staining in activated B cells and in plasma cells differentiated
in vitro from splenic B cells. Plasma cells are indicated by arrows. (C) Staining for H3K9me3 in mesenchymal, activated B and plasma cells.
(D, E) FACS analysis was used to show that the brightly stained cells observed by immunoﬂuorescent staining were predominantly G2/M. Cells
were gated into G1 and G2/M populations by propidium iodide (PI) staining for DNA content, and staining with a-H3K9me3/S10ph was
measured in these populations.
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compared to activated B cells. This may reﬂect the very high
levels of the double H3K9me3/S10ph modiﬁcation that were
observed in plasma cells.
Analysis of the double and single modiﬁcations by western
blotting gave results that broadly supported the conclusions
from the immunostaining. In particular, the plasma cells
showed a much higher global level of the double modiﬁcation
than activated B cells (Figure 3A). The modiﬁcation was
completely absent from resting B cells. Signiﬁcant levels of
the double modiﬁcation were also present in differentiated
postmitotic C3H10T1/2 cells (Figure 3A). The levels were
somewhat lower than the level in undifferentiated cells, but
this was likely to reﬂect the fact that these cells were cycling
and therefore included signiﬁcant numbers of G2/M cells.
The levels of the single H3K9me3 and H3S10ph modiﬁcations
detected by western blotting showed only small variations
between differentiated and undifferentiated cells (Figure 3A
and B). The lower level of the H3K9me3 single modiﬁcation
that was observed by immunostaining of plasma cells com-
pared with the level measured by western blotting (Figures
2C and 3B) could be due to reduced accessibility of the
modiﬁcation to intracellular antibody staining, suggesting
that it may be located within the heterochromatin mass.
Aurora B kinase is responsible for generating the double
histone H3K9me3/S10ph modiﬁcation in non-cycling
differentiated cells
We next tested whether the histone H3K9me3/S10ph mark in
plasma cells and differentiated mesenchymal stem cells cor-
relates with the presence of the Aurora B kinase, which is
known to be responsible for generating the phospho-S10
moiety of the double modiﬁcation during mitosis (Fischle
et al, 2005). Immunostaining of postmitotic plasma cells
showed intense staining for Aurora B, which coincided with
the large DAPI-dense regions of facultative heterochromatin
(Figure 4B). More diffuse staining was also observed on the
rest of the chromatin. This pattern correlates closely with the
distribution of the H3K9me3/S10ph staining (Figure 2B). The
proportion of plasma cells that stained positively for Aurora B
(54%) was similar to the proportion that was positive for the
double modiﬁcation. Aurora B was also present in 100% of
differentiated mesenchymal cells where it was concentrated
into dot-like nuclear foci that did not coincide with constitu-
tive pericentromeric heterochromatin (Figure 4A). Activated
B cells and undifferentiated mesenchymal stem cells both
gave a pattern of Aurora B staining that was similar to the
H3K9me3/S10ph distribution with staining of the pericentro-
meric heterochromatin observed in the G2 cells and largely
absent from G1 cells (Figure 4A and B). This distribution was
conﬁrmed by FACS analysis of the levels of Aurora B in G1
and G2/M cells (Figure 4C and D).
Western blotting analysis also showed that Aurora B is
present in postmitotic plasma cells and differentiated me-
senchymal cells (Figure 4E). The analysis of undifferentiated
mesenchymal stem cells was also carried out on cells that
were sorted into G1 and G2/M populations and showed that
the level of Aurora B is higher in differentiated cells than in
undifferentiated G1 cells (Figure 4E). These results indicate
that Aurora B persists in differentiated postmitotic cells and
provide support for the idea that it is involved in the
epigenetic regulation of cell differentiation.
To directly test whether Aurora B is responsible for gen-
erating the double modiﬁcation during differentiation, in
vitro-differentiated plasma cells were treated with hespera-
din, which speciﬁcally inhibits Aurora B activity (Hauf et al,
2003). Inhibition of the kinase resulted in a drastic reduction
in the amount of H3K9me3/S10ph modiﬁcation that was
observed by western blotting (Figure 4F). This leads us to
conclude that phosphorylation of H3 S10 by Aurora B is
responsible for increasing the level of double H3K9me3/
S10ph modiﬁcation in postmitotic plasma cells.
Phosphorylation of histone H3 S10 blocks binding of
HP1b to di- and tri-methylated K9
The presence of phosphorylated S10 has the potential to
affect binding of proteins that recognise the adjacent methy-
lated K9. One possible candidate for such an effect is HP1.
Phosphorylation of S10 has been shown to modulate the
binding of HP1 proteins to methylated histone H3K9,
although different effects have been reported and there
have been conﬂicting results for binding of different HP1
family members to di- and tri-methyl H3K9 (Mateescu et al,
2004; Fischle et al, 2005). We used surface plasmon
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Figure 3 Global levels of H3K9me3/S10ph following cell differentia-
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on the in vitro binding of HP1b to di- and tri-methyl H3K9.
The SPR assay made use of a recombinant 6 His-HP1b
protein and H3 peptides containing covalent modiﬁcations.
Phosphorylation of S10 markedly decreased the interaction of
HP1b with both K9me3 and K9me2 peptides (Figure 5A).
This result supports the idea that S10 phosphorylation
forms part of a binary switch that regulates binding of
HP1b to chromatin.
Aurora B-dependent release of HP1b from
heterochromatin in plasma cells
We next set out to investigate whether the presence of the
double H3K9me3/S10ph modiﬁcation affects the in vivo
binding of HP1b to chromatin during cell differentiation.
Immunostaining was used to determine whether HP1b is
associated with the facultative heterochromatin of plasma
cells (Figure 5C). In activated B cells, HP1b showed the
expected localisation to pericentromeric heterochromatin
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Figure 4 Aurora B persists in the nucleus following differentiation and its kinase activity is required for generation of the double H3K9me3/
S10ph mark in differentiated postmitotic cells. (A) Distribution of Aurora B in undifferentiated and differentiated C3H10T1/2 cells. (B) Staining
of Aurora B in activated B and plasma cells. (C, D) FACS analysis was used to show that the brightly stained cells observed by
immunoﬂuorescent staining were predominantly G2/M. Cells were gated into G1 and G2/M as in Figure 2 and staining with a-Aurora B
was measured. (E) Whole-cell extracts from puriﬁed resting B, activated B and plasma cells and undifferentiated and differentiated C3H10T1/2
cells were analysed by western blotting using an a-Aurora B antibody. Aurora B levels were also measured in undifferentiated C3H10T1/2 cells
that had been FACS sorted into G1 and G2/M populations (right panel; see Materials and methods for details). (F) Western blot with
a-H3K9me3/S10ph of acid-extracted proteins from plasma cells cultured for 1h with 200nM Aurora B inhibitor hesperadin or in medium alone.
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on in vitro-differentiated plasma cells, HP1b was depleted
from the heterochromatic regions and was present more
abundantly in regions of the nucleus that stained less brightly
with DAPI. The cytoplasmic HP1b staining in plasma cells
was mainly due to crossreactivity of the secondary anti-rat
antibody with mouse immunoglobulins (Igs) (Figure 5D).
Western blot analysis showed that HP1b is still present in
plasma cells, thereby excluding the possibility that the ab-
sence of heterochromatin staining is due to loss of HP1b from
the cell (Figure 3C).
To test whether the results obtained with the in vitro-
differentiated cells reﬂected the distribution of HP1 in plasma
cells in vivo, we assessed HP1b localisation in the nuclei of
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Figure 5 HP1b is relocated away from heterochromatin in plasma cells. (A) Surface plasmon resonance (SPR) analysis of binding of His-HP1b
to peptides corresponding to aa 1–15 of histone H3 with the indicated modiﬁcations. Peptides (50mM) were injected over His-HP1b
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Aurora B marks silent genes during differentiation
P Sabbattini et al
&2007 European Molecular Biology Organization The EMBO Journal VOL 26 | NO 22 | 2007 4663short- and long-lived plasma cells isolated ex vivo. The short-
lived plasma cells were isolated from spleens of LPS-immu-
nised mice and the long-lived plasma cells were obtained
from the bone marrow of mice that had been immunised with
ovalbumin (see Materials and methods). Interestingly, the
two types of cells gave different results. The short-lived
splenic plasma cells had a similar HP1b distribution to the
in vitro-differentiated cells, whereas in the long-lived bone
marrow cells, the localisation of HP1b to the heterochromatin
was restored (Figure 5C). Analysis of the subnuclear localisa-
tion of HP1b in differentiated C3H10T1/2 cells showed that it
is not visibly delocalised from heterochromatin (data not
shown). This can be explained by the lower levels of the
double H3K9me3/S10ph modiﬁcation in these cells compared
with plasma cells.
To establish whether Aurora B activity is responsible for
HP1b release from heterochromatin in short-lived plasma
cells, we analysed the effect of the Aurora B inhibitor
hesperadin on HP1b distribution in plasma cell nuclei.
Incubation of in vitro-differentiated plasma cells with hesper-
adin for 1.5h resulted in relocalisation of HP1b to the
heterochromatic foci in 29% of the cells (Figure 5E), com-
pared with 1% of untreated cells. This result demonstrates
that Aurora B is involved in modulating the interaction of
HP1b with chromatin outside mitosis. The comparison be-
tween different types of plasma cells also suggests that the
binding of HP1b to heterochromatin is part of a complex
phenomenon, with other factors coming into play during the
transition from short- to long-lived plasma cells.
Domains of H3K9me3/S10ph form at repressed genes in
differentiated cells
The association of the double H3K9me3/S10ph modiﬁcation
with facultative heterochromatin in plasma cells suggests that
it could be an epigenetic marker for gene silencing. To
address this question directly, a custom oligonucleotide tiling
microarray was used to analyse the modiﬁcation at the level
of individual genes and to relate it to transcriptional activity.
The microarray covered a 2-Mb gene-rich region of mouse
chromosome 3, with an average resolution of 100bp
(Figure 6). The 67 genes in the region have a variety of
expression patterns ranging from ubiquitous to highly tissue
speciﬁc. Expression of all of the genes was measured in
C3H10T1/2 cells before and after differentiation by quantita-
tive real-time PCR (data not shown).
Chromatin from undifferentiated and differentiated
C3H10T1/2 cells was precipitated using the a-H3K9me3/
S10ph and a-H3K9me3 antibodies and the DNA was hybri-
dised to the microarray. Inspection of the pattern obtained for
H3K9me3/S10ph revealed a strong enrichment for the double
modiﬁcation on repressed genes in differentiated cells (de-
ﬁned by average positive log2 IP/input ratio) (Figure 6,
yellow shadowed domains). In contrast, a generally negative
log2 ratio for K9me3/S10ph was found at transcriptionally
active genes (purple shadowed domains). A striking feature
of the pattern of enrichment of the double modiﬁcation was
that it appears to deﬁne domains that can extend across
several adjacent repressed genes (Figures 6 and 7). The
pattern is dependent on differentiation, as enrichment
for H3K9me3/S10ph on repressed genes was not observed
in undifferentiated C3H10T1/2 cells (Figures 6 and 7,
light-blue trace).
In contrast, the highest levels of the single H3K9me3
modiﬁcation are observed in undifferentiated cells, with
peaks of enrichment present on active and silent genes
(Figure 6, light-green trace). When the cells were differen-
tiated, it was no longer possible to detect signiﬁcant levels of
the single modiﬁcation (Figure 6, dark-green trace) and this
was mirrored by the increase in the level of the double
modiﬁcation. This result suggests that H3K9me3 becomes
widely modiﬁed by the presence of S10ph during cell differ-
entiation, with the double H3K9me3/S10ph modiﬁcation
forming domains across silent genes.
Conventional chromatin immunoprecipitation (ChIP)
using quantitative real-time PCR was also carried out on
activated B and plasma cells and was compared with the
results from undifferentiated and differentiated mesenchymal
cells. The results show increased levels of the double modi-
ﬁcation at silent genes in plasma cells compared with
activated B cells (Supplementary Figure S3). Taken together,
the data from the microarray and the PCR–ChIP analysis
indicate that the H3K9me3/S10ph modiﬁcation becomes
progressively enriched at repressed genes as cells differenti-
ate and suggest that it forms part of a mechanism for
epigenetic marking of silent chromatin in differentiated post-
mitotic cells.
Discussion
A novel function for the Aurora B kinase in differentiated
postmitotic cells
The results of this study add a new dimension to the biology
of the Aurora B kinase by showing that it can act as a
regulator of the epigenetic status of differentiated postmitotic
cells. Previous work had shown that Aurora B is tightly
regulated in cycling cells and phosphorylates proteins that
are critical for the transit through mitosis (Carmena and
Earnshaw, 2003). Aurora B expression is upregulated during
the transition from S to G2, peaks in G2/M and is minimal
in interphase (Terada et al, 1998). The observation that
Figure 6 ChIP-on-chip analysis shows enrichment for H3K9me3/S10ph on repressed gene domains in differentiated C3H10T1/2 cells. The
tiling microarray covers a 2-Mb region of mouse chromosome 3 containing 67 genes with different expression patterns (yellow¼silent gene;
purple¼active gene). All the genes coloured in yellow are silent in both undifferentiated and differentiated cells with the exception of nestin,
which is expressed in mesenchymal stem cells and silenced during differentiation. Domains of H3K9me3/S10ph enrichment, corresponding to
log2 ratios above 0, are shadowed in yellow while domains of depletion (negative log2 ratios) are shadowed in purple. Data are represented in
the upper tracing as the scaled log2 ratio (pull-down/input) of the hybridisation signal for DNA immunoprecipitated using the indicated
antibody (dark-blue tracing¼H3K9me3/S10ph in differentiated C3H10T1/2; light-blue tracing¼H3K9me3/S10ph in undifferentiated
C3H10T1/2; dark green¼H3K9me3 in differentiated C3H10T1/2; light green¼H3K9me3 in undifferentiated C3H10T1/2). The distribution
of peaks of enrichment is shown in the panel below each tracing. The peaks are color-coded (red¼high probability peak, false discovery rate
(FDR)p0.05; yellow¼intermediate probability peak, FDR40.1 and p0.2; grey¼low probability peak, FDR40.2) and were obtained using
the NimbleGen default algorithm described in Materials and methods and in http://www.nimblegen.com/products/lit/nimblescan2.3users-
guide.pdf. Validation of the microarray analysis by real-time PCR is described in Supplementary Figure S4.
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controlled cell division in many types of cancer has rein-
forced the perception that the Aurora B kinase is primarily
involved in cell-cycle regulation (Tatsuka et al, 1998).
However, our results provide evidence that Aurora B also
has important functions in non-dividing cells.
In dividing cells, Aurora B is known to be responsible for a
transient peak of histone H3S10 phosphorylation, which
generates the double H3K9me3/S10ph modiﬁcation at the
G2/M phase of the cell cycle. This leads to the release of HP1b
and to chromatin changes necessary for chromosome segre-
gation (Fischle et al, 2005; Hirota et al, 2005). Our study
demonstrates that the double H3K9me3/S10ph modiﬁcation
is not restricted to mitotic cells, but is also found at high
levels in differentiated postmitotic cells and that its presence
depends on the activity of Aurora B.
A particularly striking feature of plasma cell differentiation
is the formation of large clusters of facultative heterochro-
matin as the nucleus shrinks and the cell specialises to
become an antibody factory. The double H3K9me3/S10ph
modiﬁcation is strongly associated with these heterochro-
matic regions. It is interesting that plasma cells show no
detectable increase in the levels of H3K9me3 without the
accompanying S10ph despite there being a substantial in-
crease in the amount of heterochromatin in these cells
compared with activated B cells. This suggests that the
presence of S10ph modiﬁcation has an important role in
modulating the epigenetic marking of facultative heterochro-
matin by H3K9me3 during cell differentiation. Previous stu-
dies have implicated H3 S10 phosphorylation in gene
activation (reviewed in Johansen and Johansen, 2006). Our
results suggest that the combination of S10 phosphorylation
with K9 methylation can reverse this effect and turn the
modiﬁcation into a silencing mark.
The double histone H3K9me3/S10ph modiﬁcation is a
marker for gene silencing during differentiation
Microarray and conventional ChIP analysis of the distribution
of the double H3K9me3/S10ph modiﬁcation revealed a deve-
lopmentally regulated association of the modiﬁcation with
gene silencing. Differentiation of mesenchymal stem cells is
accompanied by the formation of domains of enrichment for
the double modiﬁcation that can extend across several ad-
jacent silent genes. There is a corresponding decrease in log2
ratios and in the number of enrichment peaks observed for
the single H3K9me3 modiﬁcation, which suggests that it is
converted into the double modiﬁcation by addition of the
phosphate group at S10. The highest levels of the double
modiﬁcation were present in terminally differentiated plasma
cells, as measured by IF, western blotting and ChIP of
individual genes. These results suggest that the complexity
of epigenetic regulation can be increased during cell differ-
entiation, as the readout from single modiﬁcations is subject
to progressive modulation by the addition of new modiﬁca-
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Figure 7 Close-up view of the repressed gene domains within the 2-Mb region. Horizontal arrows indicate the direction of transcription
(yellow¼silent gene; purple¼active gene).
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inﬂuence the binding of chromatin proteins, either by creat-
ing new binding sites or by preventing proteins from binding
to existing sites.
Aurora B generates a binary methyl/phospho switch
that modulates HP1 binding to chromatin during
differentiation
A key observation in this study is the ﬁnding that HP1b is
displaced from facultative heterochromatin in short-lived
plasma cells and that this displacement is reversed by inhibi-
tion of Aurora B. HP1 is a major component of constitutive
heterochromatin, which is conserved in a wide range of
organisms from ﬁssion yeast through to mammals. It binds
to methylated H3K9 (Jacobs and Khorasanizadeh, 2002;
Nielsen et al, 2002) and recruits the Su(Var)39 histone
methyltransferase (Schotta et al, 2002), thereby promoting
further H3K9 methylation and reinforcing the process of
heterochromatinisation. HP1 also recruits histone deacety-
lases, cohesin and the CAF1 chromatin assembly complex
(reviewed in Maison and Almouzni, 2004; Hediger and
Gasser, 2006).
Although HP1 has been thought to be associated mainly
with gene silencing, recent studies have shown that it is
associated with transcriptionally active chromatin puffs on
Drosophila polytene chromosomes (Piacentini et al, 2003)
and that it binds within the transcribed regions of a number
of active Drosophila genes (de Wit et al, 2007). Together with
studies that have revealed the presence of methylated H3K9
within active transcription units (Vakoc et al, 2005), these
results point to a dual role for HP1 in activating and silencing
transcription. This conclusion has received further support
from studies in Schizosaccharomyces pombe showing that
Swi6/HP1 recruits the chromatin opening protein Epe1,
which in turn makes heterochromatin more accessible to
transcription by RNA polymerase II, a necessary precursor
to RNAi-mediated heterochromatinisation (Zofall and
Grewal, 2006). Displacement of HP1 from chromatin would,
therefore, be expected to have complex effects on activation
and silencing of transcription.
These results raise the possibility that displacement of HP1
could be important for long-term silencing of gene expression
in differentiated cells. A second effect of displacing HP1 could
be to allow binding of other, as yet, unidentiﬁed chromatin
proteins that would recognise the double modiﬁcation and
would be involved in maintaining transcriptional silencing
and formation of facultative heterochromatin. This idea is
supported by the observation that HP1 is absent from facul-
tative heterochromatin in chicken erythrocytes (Gilbert et al,
2003). However, the absence of HP1 from chicken erythrocyte
heterochromatin appears to be due to complete loss of HP1
from the nucleus rather than a histone modiﬁcation displa-
cing HP1 from chromatin.
Our data indicate that the single H3K9me3 modiﬁcation is
converted by the Aurora B kinase into a double H3K9me3/
S10ph modiﬁcation on a proportion of nucleosomes at re-
pressed genes. The double H3K9me3/S10ph modiﬁcation
would also generate a novel binding site that has the potential
to be recognised by other proteins that participate in the
formation of a permanent repressive structure.
A key requirement for generating the binary methyl/phos-
pho switch in differentiated postmitotic cells is the uncou-
pling of Aurora B kinase regulation from the cell cycle. This is
likely to involve association of the kinase with a different set
of proteins as cells exit from the cell cycle. Identiﬁcation of
the factors that lead to this change in Aurora B function will
be an important area of future research.
Materials and methods
Antibodies
The following antibodies were used in western blot analysis, ChIP
and IF: a-histone H3 (Abcam ab1791), a-H4 (Upstate 07-108),
a-H3K9me3/S10ph (Abcam ab5819) (peptide ELISA to conﬁrm the
speciﬁcity of this antibody was carried out as described previously;
Chow et al, 2005), a-H3K9me3 (Upstate 07-442), a-Aurora B
(Abcam ab2254), a-HP1b (anti-M31 rat monoclonal MCA1946;
Serotec), a-mouse IgM-Texas red (Vector) and a-mouse IgG-Texas
red (vector), a-b-tubulin (Santa Cruz Biotechnologies) and a-actin
(Sigma). Control antibodies for ChIP were nonspeciﬁc rabbit IgG
(Santa Cruz Biotechnologies) and a-FLAG antibody (Sigma).
Secondary antibodies for western blot studies were a-rabbit IgG-
horseradish peroxidase-conjugated antibody (Sigma) and a-rabbit
IgG-alkaline phosphatase-conjugated antibody (Sigma).
Cell cultures
Resting B-cell isolation and B-cell activation were carried out as
described previously (Sabbattini et al, 2001). The activated B cells
were positively selected with biotinylated anti-CD19 antibody (BD
Biosciences Pharmingen) conjugated to streptavidin beads (CEL-
Lection Dynabeads; Dynal) and released from the beads before
further analysis.
C3H10T1/2 cells were expanded in complete expansion medium,
DMEM medium supplemented with 10% FCS, 100U/ml penicillin,
100 mg/ml streptomycin, 2mM glutamax, 2mM non-essential amino
acids (Sigma) and 2mM sodium pyruvate. Osteogenic differentia-
tion was induced as described in Peister et al (2004) by culturing the
C3H10T1/2 cells in IMDM supplemented with 10% FCS, 10% HS,
100U/ml penicillin, 100mg/ml streptomycin, 2mM glutamax,
20mM b-glycerolphosphate, 50ng/ml thyroxine, 1nM dexametha-
sone and 0.5mM ascorbic acid (all from Sigma) for 3 weeks. To
conﬁrm differentiation, an aliquot of the cells was ﬁxed for 2min
with 1% formaldehyde and then stained for phosphatase activity
using OPD (Dako) as a chromogenic substrate. Real-time PCR was
used to conﬁrm expression of the osteogenic markers alkaline
phosphatase and osteocalcin. For BrdU incorporation studies,
C3H10T1/2 cells were incubated in media with 10mM BrdU for 2h.
In vitro differentiation and selection of plasma cells
Spleens from 6- to 10-week-old CBAB6F1 mice were disaggregated
and the single-cell suspension was centrifuged on a Ficoll cushion
to remove erythrocytes and cultured for 7 days in RPMI
supplemented with 15% FCS, 50mM 2-mercaptoethanol, 50mg/ml
gentamicin, 25mg/ml LPS, 5ng/ml IL-5, 5ng/ml IL-6 and 10ng/ml
IL-10. On day 7, the cells were again centrifuged on a Ficoll cushion
to remove dead cells and the cells obtained from the interface were
blocked with 10% goat serum and 5mg/ml anti-FC receptor g III/II
(BD Biosciences Pharmingen). The cells were then incubated with
streptavidin beads (CELLection Dynabeads; Dynal) conjugated with
biotinylated a-syndecan-1 antibody (BD Biosciences Pharmingen).
Following magnetic selection, the cells were washed and released
from the beads by digestion with DNaseI and incubated with
a-B220-conjugated magnetic beads (Dynal) to deplete the B220
þ
cells. After selection, the cultures were typically 497% a-syndecan-
1
þ/498% B220
 . For plasma cell isolation ex vivo from bone
marrow, mice were immunised with ovalbumin, followed by a
second immunisation after 3 weeks. Bone marrow was collected 3
days after the second immunisation. Plasma cells were isolated
from spleen 7 days after immunisation with LPS. Plasma cell-
enriched cell preparations from bone marrow and spleen were
obtained by centrifugation on a Ficoll cushion followed by positive
selection with a-syndecan-1 antibody conjugated to magnetic
beads. For BrdU incorporation assays, activated B and plasma cells
were incubated in media with 10mM BrdU for 6h.
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IF analysis was carried out as described previously (Mak et al,
2002). Secondary antibodies used for ﬂuorescent detection were
Alexa 488 anti-rabbit and Alexa 488 anti-rat (both from Molecular
Probes). Samples were mounted in Vectashield supplemented with
DAPI (10mg/ml) and images were collected by confocal microscopy
using a TCS-SP1 microscope (Leica Microsystems) and Metamorph
4.0 software.
ChIP
ChIP analysis of unﬁxed chromatin or formaldehyde-ﬁxed chroma-
tin was carried out as described previously (Szutorisz et al, 2005).
For plasma cells, the ChIP was carried out in the presence of SL2
Drosophila cells according to the carrier ChIP protocol described
previously (O’Neill et al, 2006). Unﬁxed chromatin (150mg)
was immunoprecipitated with the following antibodies: 20mlo f
anti-diacetylated histone H3 (Upstate 06-599), 100ml a-H3K9me3/
S10ph (Abcam ab5819), 20ml a-H3K9me3 (Upstate) and as control
37ml nonspeciﬁc rabbit IgG (Santa Cruz Biotechnology). For the
ﬁxed chromatin method, 500mg of ﬁxed chromatin was immuno-
precipitated and the same ratio of chromatin to antibody was used
that was described for the unﬁxed chromatin procedure. The input
and immunoprecipitated samples were phenol/chloroform-ex-
tracted and resuspended in 100ml of TE. For quantitation, 2mlo f
the input and the immunoprecipitated DNA (IP) samples were
ampliﬁed by real-time PCR using SYBR–green mix (Bio-Rad) and a
DNA Engine Opticon system (MJ Research Inc.). PCRs were carried
out in duplicate. Primer sequences can be obtained on request.
Microarray analysis
Microarrays were generated by NimbleGen Systems by tiling 50-bp
oligonucleotides across a region of 2Mb of mouse chromosome 13
(Chr3: 87462375–89534891) with 100-bp resolution. High-frequency
repeats were excluded by repeat masking. DNA (4mg) from
immunoprecipitation and input was ampliﬁed using the Genome-
Plex WGA kit (Sigma). After ampliﬁcation, the DNA was tested for
enrichment at control loci and compared to the unampliﬁed DNA by
real-time PCR. The ampliﬁed input and pull-down DNA were
labelled with Cy3 and Cy5 by random priming and hybridised to the
microarray by NimbleGen. Two immunoprecipitations were per-
formed for each antibody. Input and pull-down signal intensities,
scaled log2 ratios and enrichment peaks were provided by
NimbleGen. Enrichment peaks were calculated using a permuta-
tion-based algorithm (see NimbleScan User’s Guide at http://
www.nimblegen.com/products/lit/nimblescan2.3usersguide.pdf,
default algorithm). This estimates the false discovery rate (FDR) for
each peak, which is equal to the probability of ﬁnding a peak of
comparable signiﬁcance by chance. Signiﬁcant peaks are charac-
terised by low FDRs and correspond to four or more probes within a
500-bp sliding window with signals above the cutoff value (cutoff
values are a percentage ranging from 90 to 15% of a hypothetical
log2 ratio maximum, which is the meanþ6(standard deviation)).
In vitro binding analysis by SPR
The assays were performed on a Biacore X instrument (Biacore,
Milton Keynes, UK) with Biacore HBS-EP buffer (10mM Hepes pH
7.4, 0.15M NaCl, 3mM EDTA, 0.005% Tween 20) at a ﬂow rate of
10 ml/min. Anti-6  His monoclonal antibody (Abcam; 6500
response units, RUs) and control anti-RNA polII monoclonal
antibody (kind gift of Laszlo Tora; 6700RU) were immobilised
using the Amine Coupling Kit (Biacore) on ﬂow cells 1 and 2,
respectively, of a CM5 sensor chip. 6 His-HP1b (300nM) was
injected simultaneously over ﬂow channels 1 and 2 followed by
injection over both ﬂow channels of 50mM solutions of peptides for
2min. After the injection, the dissociation of the complex was
followed for 180s. Non-phosphorylated peptides were also injected
at lower concentrations for comparability to phosphorylated
peptide binding. The difference between the increase in RU between
ﬂow channels 1 and 2 was used to measure the speciﬁc binding of
the peptides to His-HP1b. At least two injections were carried out
for each peptide. Data were analysed using Bioevaluation 3.2
software (Biacore).
FACS sorting of G1 and G2/M cells
Live logarithmically growing undifferentiated C3H10T1/2 cells
(2 10
7) were stained for 30min at 371C/5% CO2 with the DNA-
intercalating dye Hoechst 33342 (10mg/ml). The cells were sorted
by FACS into G1 and G2/M fractions on the basis of DNA content.
Sorting was carried out with a FACS Vantage SE sorter (Becton
Dickinson).
Supplementary data
Supplementary data are available at The EMBO Journal Online
(http://www.embojournal.org).
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